Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
CervoMed Inc. is a clinical-stage company focused on developing treatments for age-related neurologic disorders. The Company is developing neflamapimod, an investigational, orally administered small molecule brain penetrant that inhibits p38 mitogen-activated protein kinase alpha. Neflamapimod has the potential to treat synaptic dysfunction, the reversible aspect of the underlying neurodegenerative processes that cause disease in Lewy bodies (DLB) and certain other neurological disorders. It focuses on reducing the impact of inflammation in the brain, or neuroinflammation, which is a key factor in the manifestation of degenerative diseases of the brain, including DLB. Neflamapimod is being evaluated in the Company's ongoing RewinD-LB Trial, a Phase 2b trial in patients with DLB.
Find out what a historical investment in CervoMed Inc would be worth today using our CRVO stock calculator.
Buying CRVO shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in CervoMed Inc in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in CRVO
What is the ticker symbol of CervoMed Inc?
The ticker symbol for CervoMed Inc is CRVO.
How much is one share of CRVO?
One share of CRVO is valued at $1.33 as of 20 November 2026.
What is the market capitalisation of CervoMed Inc CRVO?
As of 20 November 2026 CervoMed Inc has a market cap of $21.94M.
What is the 52-week high for CervoMed Inc stock?
The CervoMed Inc 52-week high stock price is $10.00.
What is the 52-week low for CervoMed Inc stock?
The CervoMed Inc 52-week low stock price is $1.27.
Can I buy CRVO shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy CRVO shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in CRVO on Stake
Buy CRVO from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of CRVO from only US$10 with fractional shares